← Back to Patent Explorer
US4936835A Expired / Lapsed US ⏱️ 0.0 years remaining

Medical needle with bioabsorbable tip

Assignee: Individual
•
Filing: 1988-12-23
•
Granted: 1990-06-26
•
Expires: 2008-12-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An improved medical needle is disclosed which has a bioabsorbable gelatin cutting or puncturing tip formed therein. The gelatin characteristic renders the needle incapable of penetration after initial use. Additionally, the gelatin partially dissolves to leave a coating on the punctured tissue margin which acts to minimize hemorrhaging complications. Hemorrhaging complications are alternatively addressed by a non-bioabsorbable in situ sheath positioned at the punctured tissue site which compresses the tissue.

Inventors

  • 👤 John R. Haaga

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 20:14
CPC Classifications
A; A61; A61B; A61B10/00; A61B10/02; A61B10/0233; A61B17/00; A61B17/0057; A61B2017/00004; A61B17/12; A61B2017/12004; A61B90/00; A61B90/39; A61B2090/3904; A61B2090/3908

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 225 words
A hypodermic needle for injecting liquid medicant into the subcutaneous tissue of a patient comprising a syringe and a hollow metal cylinder, said cylinder having a proximal end in fluid communication with said syringe and its opposite, distal end sharpened to a pointed, cutting end for puncturing said tissue, said cutting end formed of a hardened bioabsorbable gelatin material said cutting edge moistened by said liquid medicant to reduce its coefficient of friction when puncturing said tissue while depositing a portion of said bioabsorbable material at the margin of said tissue when said needle is removed from said tissue to produce adherence of the margins of said tissue and prevent leakage of blood from the needle puncture, said cutting edge, being biodegradable, rendered useless for tissue puncture after its initial tissue puncture; and said gelatin base cutting end comprises a tip having a base portion adjacent the distal end of said hollow cylinder and a pointed cutting edge opposite said base portion, said tip tapering radially outwardly from said cutting edge to said base portion larger than the outside diameter of said hollow cylinder to form an arrow head configuration such that said tissue contacts said base portion adjacent said hollow cylinder after insertion and is effective to remove said tip from said hollow cylinder prior to disintegration when said needle is withdrawn after injection.
Claim 2
Dependent Claim 225 words
A hypodermic needle for injecting liquid medicant into the subcutaneous tissue of a patient comprising a syringe and a hollow metal cylinder, said cylinder having a proximal end in fluid communication with said syringe and its opposite, distal end sharpened to a pointed, cutting end for puncturing said tissue, said cutting end formed of a hardened bioabsorbable gelatin material said cutting edge moistened by said liquid medicant to reduce its coefficient of friction when puncturing said tissue while depositing a portion of said bioabsorbable material at the margin of said tissue when said needle is removed from said tissue to produce adherence of the margins of said tissue and prevent leakage of blood from the needle puncture, said cutting edge, being biodegradable, rendered useless for tissue puncture after its initial tissue puncture; and said gelatin base cutting end comprises a tip having a base portion adjacent the distal end of said hollow cylinder and a pointed cutting edge opposite said base portion, said tip tapering radially outwardly from said cutting edge to said base portion larger than the outside diameter of said hollow cylinder to form an arrow head configuration such that said tissue contacts said base portion adjacent said hollow cylinder after insertion and is effective to remove said tip from said hollow cylinder prior to disintegration when said needle is withdrawn after injection.
Claim 3
Dependent Claim 299 words
A hypodermic needle for injecting liquid medicant into the subcutaneous tissue of a patient comprising a syringe and a hollow metal cylinder, said cylinder having a proximal end in fluid communication with said syringe and its opposite, distal end sharpened to a pointed, cutting end for puncturing said tissue, said cutting end formed of a hardened bioabsorbable gelatin material said cutting edge moistened by said liquid medicant to reduce its coefficient of friction when puncturing said tissue while depositing a portion of said bioabsorbable material at the margin of said tissue when said needle is removed from said tissue to produce adherence of the margins of said tissue and prevent leakage of blood from the needle puncture, said cutting edge, being biodegradable, rendered useless for tissue puncture after its initial tissue puncture; said gelatin base cutting end comprises a tip having a base portion adjacent the distal end of said hollow cylinder and a pointed cutting edge opposite said base portion, said tip tapering radially outwardly from said cutting edge to said base portion larger than the outside diameter of said hollow cylinder to form an arrow head configuration such that said tissue contacts said base portion adjacent said hollow cylinder after insertion and is effective to remove said tip from said hollow cylinder prior to disintegration when said needle is withdrawn after injection; and said tip portion is generally solid, and closes said distal end of said hollow cylinder, said distal end having at least one small aperture extending through the side thereof, said syringe effective to force said liquid medication through said aperture while simultaneously slightly dislodging said top from said hollow cylinder and means in said base portion for initially retaining said to to said hollow cylinder prior to injection of said medication into the patient.
Claim 4
Dependent Claim 299 words
A hypodermic needle for injecting liquid medicant into the subcutaneous tissue of a patient comprising a syringe and a hollow metal cylinder, said cylinder having a proximal end in fluid communication with said syringe and its opposite, distal end sharpened to a pointed, cutting end for puncturing said tissue, said cutting end formed of a hardened bioabsorbable gelatin material said cutting edge moistened by said liquid medicant to reduce its coefficient of friction when puncturing said tissue while depositing a portion of said bioabsorbable material at the margin of said tissue when said needle is removed from said tissue to produce adherence of the margins of said tissue and prevent leakage of blood from the needle puncture, said cutting edge, being biodegradable, rendered useless for tissue puncture after its initial tissue puncture; said gelatin base cutting end comprises a tip having a base portion adjacent the distal end of said hollow cylinder and a pointed cutting edge opposite said base portion, said tip tapering radially outwardly from said cutting edge to said base portion larger than the outside diameter of said hollow cylinder to form an arrow head configuration such that said tissue contacts said base portion adjacent said hollow cylinder after insertion and is effective to remove said tip from said hollow cylinder prior to disintegration when said needle is withdrawn after injection; and said tip portion is generally solid, and closes said distal end of said hollow cylinder, said distal end having at least one small aperture extending through the side thereof, said syringe effective to force said liquid medication through said aperture while simultaneously slightly dislodging said top from said hollow cylinder and means in said base portion for initially retaining said to to said hollow cylinder prior to injection of said medication into the patient.
Claim 5
Dependent Claim 40 words
The needle of claim 2 wherein said tip has a barb protrusion formed in said frusto conical surface between said cutting edge and said base portion and shaped to permit said top to enter said tissue while resisting exit therefrom.

References Cited (Backward Citations)

US2603217A Cited
US2691373A Cited
US2814296A Cited
US3106483A Cited
US3396727A Cited
US3358684A Cited
US3736939A Cited
US4564361A Cited
US4306563A Cited
US4650488A Cited
US4708147A Cited
US4710181A Cited
US4827940A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-06-25 1993-12-25 1994-06-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-06-25 1997-12-25 1998-06-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-06-25 2001-12-25 2002-06-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag